Seeking to Stop “Foreign Freeloaders,” CMS Proposes Revised Pricing for Part B Drugs Based on International Prices
Following the release of an HHS report on international drug pricing, President Trump announced a new Department of Health and Human Services (HHS) initiative to index pricing for Medicare Part B drugs to international prices. The advance notice of proposed rulemaking solicits comments on a demonstration program HHS is considering that would test changes to [...] Read More